Saleh Baeesa | Medicine | Innovative Research Award

Innovative Research Award

Saleh Baeesa
Affiliation King Faisal Specialist Hospital & Research Centre
Country Saudi Arabia
Google Scholar ID 0nVbgSEAAAAJ
Documents 275
Citations 4,221
h-index 33
Subject Area Medicine
Event International Material Scientist Awards

Saleh Baeesa is affiliated with King Faisal Specialist Hospital & Research Centre, Saudi Arabia, and has established a notable academic profile in the field of medicine. Through a sustained record of scientific publications, clinical research contributions, and scholarly engagement, he has contributed to the advancement of medical knowledge and evidence-based healthcare practices. His academic impact is reflected through publication productivity, citation performance, and interdisciplinary research activities, making his profile relevant for consideration within the framework of the Innovative Research Award recognition program.[1]

Abstract

This article presents an academic overview of Saleh Baeesa and highlights research achievements relevant to the Innovative Research Award. The profile demonstrates scholarly productivity, research dissemination, and measurable academic influence through publications, citations, and interdisciplinary collaborations. The documented body of work reflects sustained contributions to medical science and clinical research while supporting the advancement of healthcare knowledge and innovation.[1][2]

Keywords

  • Innovative Research Award
  • Medicine
  • Clinical Research
  • Scientific Publications
  • Healthcare Innovation
  • Research Impact

Introduction

The advancement of medical science depends upon the continuous efforts of researchers who contribute to evidence generation, clinical innovation, and scientific dissemination. Academic recognition programs acknowledge individuals whose work demonstrates measurable impact and scholarly excellence. Saleh Baeesa’s publication record and citation performance indicate a sustained engagement with scientific inquiry and knowledge development within the medical sciences.[1]

Research Profile

Based at King Faisal Specialist Hospital & Research Centre, Saleh Baeesa has developed an extensive scholarly profile characterized by publication activity and citation visibility. The available metrics indicate 275 indexed documents, more than 4,200 citations, and an h-index of 33. These indicators suggest broad dissemination of research findings and meaningful engagement from the academic community.[1]

  • Institution: King Faisal Specialist Hospital & Research Centre
  • Country: Saudi Arabia
  • Subject Area: Medicine
  • Documents: 275
  • Citations: 4,221
  • h-index: 33

Research Contributions

The research contributions associated with Saleh Baeesa encompass clinical investigations, medical knowledge dissemination, and collaborative scientific studies. Through peer-reviewed publications and scholarly engagement, the research portfolio supports ongoing improvements in healthcare understanding and clinical practice. Such contributions align with the broader objectives of translational medicine, patient-centered outcomes, and evidence-based decision-making.[2]

The cumulative research output demonstrates consistency in academic participation and contributes to the international exchange of scientific knowledge. Publication activity across recognized scholarly platforms further strengthens visibility and accessibility within the global research ecosystem.[3]

Publications

Publication metrics provide one of the most widely accepted indicators of scholarly productivity. With 275 documented research outputs, the publication portfolio demonstrates long-term engagement with scientific communication and peer-reviewed dissemination. The citation record suggests that published findings have been referenced and utilized by researchers across related disciplines.[1]

  • Peer-reviewed journal articles
  • Clinical and translational research publications
  • Collaborative scientific studies
  • Conference-related scholarly contributions

Research Impact

Research impact may be assessed through citation activity, scholarly visibility, and influence on subsequent investigations. The citation count of 4,221 and h-index of 33 indicate that a substantial portion of the published work has received recognition within the academic community. These indicators suggest enduring relevance and engagement with the research outputs over time.[1]

Beyond quantitative metrics, research impact also encompasses contributions to knowledge transfer, professional development, and the advancement of healthcare-related practices. The integration of research findings into broader scientific discourse represents an important dimension of academic influence.[2]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate sustained scholarly productivity, measurable academic impact, and meaningful contributions to their respective fields. Based on the available publication record, citation profile, and documented research engagement, Saleh Baeesa’s academic achievements align with commonly recognized indicators of research excellence and innovation.[1][2]

Participation in the International Material Scientist Awards framework provides an opportunity to acknowledge interdisciplinary research accomplishments and contributions to scientific advancement. The profile reflects characteristics frequently associated with competitive academic recognition programs.[4]

Conclusion

Saleh Baeesa’s scholarly record reflects a sustained commitment to medical research, scientific publication, and academic engagement. Through a substantial body of work supported by significant citation activity, the profile demonstrates research visibility and influence within the scientific community. These characteristics support consideration for recognition through the Innovative Research Award and similar academic distinction programs.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Saleh Baeesa. Google Scholar. https://scholar.google.com/citations?user=0nVbgSEAAAAJ&hl=en&oi=ao
  2. Effects of Radiotherapy Alone Versus Concomitant Radiotherapy With Temozolomide Chemotherapy on the Outcome of IDH-wildtype Glioblastoma Patients.
    https://www.sciencedirect.com/science/article/pii/S0936655524005454
  3. Level of evidence of abdominal surgery clinical research in Saudi Arabia.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5556293/
  4. Solitary Skull Metastasis as the First Presentation of a Metachronous Primary Lung Cancer in a Survivor from Pancreatic Cancer. https://onlinelibrary.wiley.com/doi/full/10.1155/2017/5674749
  5. Sensitivity Assessment of Wilms Tumor Gene (WT1) Expression in Glioblastoma using qPCR and Immunohistochemistry and its Association with IDH1 Mutation and Recurrence Interval. https://www.tandfonline.com/doi/full/10.2147/BTT.S323358

Ann Kurian | Biomaterials | Best Researcher Award

Ms. Ann Kurian | Biomaterials | Best Researcher Award

Ann Anu Kurian is a biomedical researcher with over seven years of experience specializing in cellular biology and RNA-based gene delivery. She holds an MS in Biomedical Science from Morehouse School of Medicine and a BTech in Biotechnology from Lovely Professional University. Currently an Associate Researcher II and Lab Manager at the Icahn School of Medicine at Mount Sinai, her work focuses on cardiac and skeletal muscle regeneration using modified mRNA technologies. She has contributed to multiple peer-reviewed publications and has been recognized with several academic honors, including a Presidential Scholarship and research presentation awards.

Ms.Ann Kurian , Icahn school of medicine, United States.

Profile

GOOGLESCHOLAR

SCOPUS

🎓 Education

Ann Anu Kurian holds a Master of Science in Biomedical Science from Morehouse School of Medicine in Atlanta, Georgia, completed between August 2015 and May 2017. She also earned a Bachelor of Technology in Biotechnology from Lovely Professional University in India, where she studied from August 2009 to May 2013.

🌟 Experience

With over seven years of research experience, Ann currently serves as an Associate Researcher II and Research Lab Manager at the Icahn School of Medicine at Mount Sinai in New York. Since November 2023, she has been working in the Gregorio Laboratory, conducting research focused on understanding the components and molecular mechanisms that regulate actin architecture in cardiac and skeletal muscle during both normal development and disease. Prior to this, she held a similar role in the Zangi Laboratory from August 2017 to November 2023, where she led projects utilizing modified mRNA to improve cardiac outcomes post-injury and managed various aspects of laboratory operations. Her professional journey began in India at VWR International from January 2014 to August 2015, where she supported chemical projects, maintained product data in SAP, and enhanced product descriptions.

🏅 Awards and Honors

Ann has been recognized for her academic and research achievements, receiving a Presidential Scholarship from Morehouse School of Medicine in 2017. The same year, she earned a travel award to attend the Georgia Academy of Science annual meeting. She also presented her research at several prestigious conferences, including the Ninth AACR Conference on The Science of Cancer Health Disparities, the Curtis L. Parker Student Research Symposium, and the Georgia Academy of Science annual meeting.

📖Skill

Ann is skilled in a wide range of technical and laboratory techniques. Her expertise includes molecular biology methods such as PCR, gel electrophoresis, cloning, RNA and DNA extraction, modified mRNA production, and LNP characterization. She is proficient in cell culture techniques, cardiomyocyte isolation, tissue sectioning, histological staining, and confocal microscopy. Her experience also includes data analysis, IVIS imaging, and statistical evaluation. She has strong capabilities in animal handling and laboratory management, including procurement, equipment maintenance, and regulatory compliance.

🔬 Research Focus

Ann’s research centers on cellular biology and RNA-based gene delivery systems, particularly in the context of cardiac and skeletal muscle biology. Her work has explored the use of modified mRNA technologies to induce gene expression for therapeutic regeneration following cardiac injury. Her contributions to the field are reflected in numerous peer-reviewed publications, addressing areas such as cardiomyocyte proliferation, ischemic injury, cardiac regeneration, and mRNA optimization.

📘 Publications

Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, I Munir, T Mehmood, K Brown, …
Year: 2020
Journal: Circulation (Volume 141, Issue 15, Pages 1249–1265)

Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction
Authors: Y Hadas, AS Vincek, E Youssef, MM Żak, E Chepurko, N Sultana, …
Year: 2020
Journal: Circulation (Volume 141, Issue 11, Pages 916–930)

Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, MTK Sharkar, E Chepurko, L Zangi
Year: 2018
Journal: Molecular Therapy – Nucleic Acids (Volume 13, Pages 133–143)

Optimization of 5′ untranslated region of modified mRNA for use in cardiac or hepatic ischemic injury
Authors: N Sultana, Y Hadas, MTK Sharkar, K Kaur, A Magadum, AA Kurian, …
Year: 2020
Journal: Molecular Therapy Methods & Clinical Development (Volume 17, Pages 622–633)

Direct reprogramming induces vascular regeneration post muscle ischemic injury
Authors: K Kaur, Y Hadas, AA Kurian, MM Żak, J Yoo, A Mahmood, H Girard, …
Year: (Year not provided)
Journal: Molecular Therapy (Volume 29, Issue 10, Pages 3042–3058)